Azithromycin in the treatment of sexually transmitted disease

Journal of Antimicrobial Chemotherapy

Volumn 25, Issue , 1990, Pages 109-114

  Steingrimsson, Olafur ^a   Olafsson, Jon Hjaltalin ^a   Thorarinsson, Hannes ^a   Ryan, Raymond W ^b   Johnson, Raymond B ^b   Tilton, Richard C ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; DOXYCYCLINE;

BACTERIUM ISOLATION; CHLAMYDIA TRACHOMATIS; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEXUAL TRANSMISSION; UREAPLASMA UREALYTICUM;

ADOLESCENT; ADULT; AZITHROMYCIN; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COMPARATIVE STUDY; DOXYCYCLINE; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; GONORRHEA; HUMAN; MALE; MIDDLE AGE; MYCOPLASMATALES INFECTIONS; NEISSERIA GONORRHOEAE; RANDOMIZED CONTROLLED TRIALS; SEXUALLY TRANSMITTED DISEASES; SUPPORT, NON-U.S. GOV'T; UREAPLASMA;

EID: 0025162305     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/25.suppl_A.109     Document Type: Article

References (11)

1. Ehret, J. M. & Judson, F. N. (1988). Susceptibility testing of Chlamydia trachomatis; from eggs to monoclonal antibodies. Antimicrobial Agents and Chemotherapy 32, 1295–9.
2. Girard, A. E., Girard, E., English, A. R., Gootz, T. D., Cimochowsky, C. R., Faiella, J. A. et al. (1987). Pharmacokinetic and in vivo studies with azithromycin (CP-62, 993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrobial Agents and Chemotherapy 31, 1948–54.
3. Centers for Disease Control (1985). Sexually transmitted diseases treatment guidelines. Morbidity and Mortality Weekly Report 34, Suppl. 4S, 75S–108S.
4. National Committee for Clinical Laboratory Standards (1985). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard M7-A. NCCLS, Villanova, Pa.
5. Retsema, J., Girard, A., Shelkly, W., Manousos, M., Anderson, M., Bright, G. et al. (1987). Spectrum and mode of action of azithromycin (CP-62, 993), a new 15-membered ring macrolide with improved potency against Gram negative organisms. Antimicrobial Agents and Chemotherapy 31, 1939–47.
6. Ripa, K. V. & Márdh, P. A. (1977). Cultivation of Chlamydia trachomatis in cycloheximide treated McCoy cells. Journal of Clinical Microbiology 6, 329–31.
7. Ryan, R. W., Kwasnik, I., Steingrimsson, O., Gudmundsson, J., Thorarinsson, H. & Tilton, R. C. (1986a). Rapid detection of Chlamydia trachomatis by an enzyme immunoassay method. Diagnostic Microbiology and Infectious Disease 5, 225–34.
8. Ryan, R. W., Kwasnik, I. & Tilton, R. C. (1986A). In vitro activity of the macrolide CP-62, 993- XZ450 against selected microorganisms. In Program and Abstracts of the Twenty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1986. Abstract 932, p. 267. American Society for Microbiology, Washington, DC.
9. Senterfit, L. B. (1983). Antibiotic sensitivity testing of mycoplasmas. In Methods in Micoplasmology, Vol. 2 (Tully, J. G. & Razin, S., Eds), pp. 397–401.
10. Shepard, M. C. (1983). Culture medium for mycoplasmas. In Methods in Micoplasmology, Vol. 1 (Tully, J. G. & Razin, S., Eds), pp. 137–46.
11. Walsh, M., Kappus, E. W. & Quinn, T. C. (1987). In vitro evaluation of CP-62, 993, erythromycin, clindamycin and tetracycline against Chlamydia trachomatis. Antimicrobial Agents and Chemotherapy 31, 811–2.